Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-319291
Filing Date
2019-12-19
Accepted
2019-12-19 17:21:14
Documents
2
Group Members
PURETECH HEALTH PLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d818553dsc13da.htm SC 13D/A 72648
2 EX-99.1 d818553dex991.htm EX-99.1 4328
  Complete submission text file 0001193125-19-319291.txt   78515
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Subject) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90283 | Film No.: 191296749
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
PureTech Health LLC (Filed by) CIK: 0001727395 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A